These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9169958

  • 1. Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system.
    Deuschle M, Schmider J, Weber B, Standhardt H, Körner A, Lammers CH, Schweiger U, Hartmann A, Heuser I.
    J Clin Psychopharmacol; 1997 Jun; 17(3):156-60. PubMed ID: 9169958
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
    Kudielka BM, Schmidt-Reinwald AK, Hellhammer DH, Kirschbaum C.
    Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735
    [Abstract] [Full Text] [Related]

  • 10. Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.
    Huang TS.
    Metabolism; 1994 May; 43(5):544-8. PubMed ID: 8177041
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gonadotropin-releasing hormone agonist in premenopausal women does not alter hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone.
    Gavin KM, Shea KL, Gibbons E, Wolfe P, Schwartz RS, Wierman ME, Kohrt WM.
    Am J Physiol Endocrinol Metab; 2018 Aug 01; 315(2):E316-E325. PubMed ID: 29631362
    [Abstract] [Full Text] [Related]

  • 13. Effective low dose tricyclic antidepressant treatment for depressed geriatric rehabilitation patients. A double-blind study.
    Lakshmanan M, Mion LC, Frengley JD.
    J Am Geriatr Soc; 1986 Jun 01; 34(6):421-6. PubMed ID: 3700932
    [Abstract] [Full Text] [Related]

  • 14. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
    Schüle C, Baghai T, Zwanzger P, Ella R, Eser D, Padberg F, Möller HJ, Rupprecht R.
    Psychopharmacology (Berl); 2003 Mar 01; 166(3):271-5. PubMed ID: 12552362
    [Abstract] [Full Text] [Related]

  • 15. Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression.
    Nelson WH, Orr WW, Stevenson JM, Shane SR.
    Arch Gen Psychiatry; 1982 Sep 01; 39(9):1033-6. PubMed ID: 7115012
    [Abstract] [Full Text] [Related]

  • 16. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug 01; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

  • 17. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
    J Clin Endocrinol Metab; 2001 Aug 01; 86(8):3545-54. PubMed ID: 11502777
    [Abstract] [Full Text] [Related]

  • 18. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
    Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
    [Abstract] [Full Text] [Related]

  • 19. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
    Sher L.
    ScientificWorldJournal; 2006 Oct 31; 6():1398-404. PubMed ID: 17086345
    [Abstract] [Full Text] [Related]

  • 20. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct 31; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.